Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cellular pathway
Biotech
Altos exits stealth with $3B, dream team C-suite and big vision
Altos starts with $3 billion in investor support, a C-suite staffed by storied leaders—Barron, Bishop, Klausner—and plans to reverse disease.
Nick Paul Taylor
Jan 19, 2022 7:50am
Startup aims to map gene signaling pathways for new drug targets
May 31, 2018 8:30am
Casma launches with $58.5M for autophagy-targeting treatments
May 3, 2018 6:00am
Vivace uncloaks with $40M, U.S.-China backing for cancer trials
Jun 28, 2017 9:55am
